InvestorsHub Logo
Followers 122
Posts 14167
Boards Moderated 0
Alias Born 06/02/2004

Re: trebeg post# 85398

Thursday, 02/26/2015 5:44:23 PM

Thursday, February 26, 2015 5:44:23 PM

Post# of 91007
Dawson James and Dinosaur have had probably about 5 months to organize funding. Clearly it is needed to move forward as there is no further stock liquidity for cd holders and with conversions in play liquidity would be muted severely... INDs and business execution requires significant funding.

YA has a finance agreement maturing with interest on March 11... This must be satisfied and it has been painfully obvious that the company has worked closely with cd holders to get to this point.

From all appearances and how they continue to delay IR, they look to be trying to coalesce all key news in a shorter time span. Logical, continued momentum and holds vicious traders at bay.

Funding must be first and surely new leadership will come with that and I tend to think a spin out to isolate from SVFC baggage is probable. International patent must be nearing finishing line which could open the door to multiple revenue generating license deals immediately and maybe some renowned partnerships. Chaum would be huge!! Then if Andrews launched key INDs with FDA guidance nodding to some leverage for the SVFC extraction process you have a huge influx of investment entering.

Folks need to realize the debt is rather small for a biotech and definitely in comparison to competition. This company just needs leadership and a capital influx to proliferate. The market cap stands at 800,000. Which is absolutely peanuts. That can literally turn on a dime..... Or penny!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.